लोड हो रहा है...
The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
BACKGROUND: Treatment for local and locoregional recurrence or second head-and-neck (H&N) cancers after previous radiotherapy is challenging, and re-irradiation carries a significantly increased risk for radiotherapy-related normal tissue toxicities and treatment failure due to a radioresistant...
में बचाया:
| में प्रकाशित: | Radiat Oncol |
|---|---|
| मुख्य लेखकों: | , , , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BioMed Central
2020
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7164259/ https://ncbi.nlm.nih.gov/pubmed/32299456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-020-01531-5 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|